6 Dimensions Capital, L.P. - Net Worth and Insider Trading

6 Dimensions Capital, L.P. Net Worth

The estimated net worth of 6 Dimensions Capital, L.P. is at least $379 Million dollars as of 2024-07-03. 6 Dimensions Capital, L.P. is the 2101 Beneficial owner of Cutia Therapeutics and owns about 61,771,710 shares of Cutia Therapeutics (HKSE:02487) stock worth over $379 Million. Details can be seen in 6 Dimensions Capital, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that 6 Dimensions Capital, L.P. has not made any transactions after 2023-06-12 and currently still holds the listed stock(s).

Transaction Summary of 6 Dimensions Capital, L.P.

To

6 Dimensions Capital, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, 6 Dimensions Capital, L.P. owns 1 companies in total, including Cutia Therapeutics (HKSE:02487) .

Click here to see the complete history of 6 Dimensions Capital, L.P.’s form 4 insider trades.

Insider Ownership Summary of 6 Dimensions Capital, L.P.

Ticker Comapny Transaction Date Type of Owner
HKSE:02487 Cutia Therapeutics 2023-06-12 2101 Beneficial owner

6 Dimensions Capital, L.P. Latest Holdings Summary

6 Dimensions Capital, L.P. currently owns a total of 1 stock. 6 Dimensions Capital, L.P. owns 61,771,710 shares of Cutia Therapeutics (HKSE:02487) as of June 12, 2023, with a value of $379 Million.

Latest Holdings of 6 Dimensions Capital, L.P.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02487 Cutia Therapeutics 2023-06-12 61,771,710 6.14 379,278,299

Holding Weightings of 6 Dimensions Capital, L.P.


6 Dimensions Capital, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, 6 Dimensions Capital, L.P. has made a total of 1 transactions in Cutia Therapeutics (HKSE:02487) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Cutia Therapeutics is the sale of 61,771,710 shares on June 12, 2023, which brought 6 Dimensions Capital, L.P. around $0.

Insider Trading History of 6 Dimensions Capital, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

6 Dimensions Capital, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

6 Dimensions Capital, L.P. Ownership Network

Ownership Network List of 6 Dimensions Capital, L.P.

No Data

Ownership Network Relation of 6 Dimensions Capital, L.P.

Insider Network Chart

6 Dimensions Capital, L.P. Owned Company Details

What does Cutia Therapeutics do?

Who are the key executives at Cutia Therapeutics?

6 Dimensions Capital, L.P. is the 2101 Beneficial owner of Cutia Therapeutics. Other key executives at Cutia Therapeutics include 2201 Interest of corporation controlled by you Pandanus Associates Inc. , 2201 Interest of corporation controlled by you Pandanus Partners L.P. , and 2201 Interest of corporation controlled by you FIL Limited .

Cutia Therapeutics (HKSE:02487) Insider Trades Summary

Over the past 18 months, 6 Dimensions Capital, L.P. made no insider transaction in Cutia Therapeutics (HKSE:02487). Other recent insider transactions involving Cutia Therapeutics (HKSE:02487) include a net sale of 3,165,600 shares made by FIL Limited , a net sale of 3,165,600 shares made by Pandanus Partners L.P. , and a net sale of 3,165,600 shares made by Pandanus Associates Inc. .

In summary, during the past 3 months, insiders sold 4,587,600 shares of Cutia Therapeutics (HKSE:02487) in total and bought 0 shares, with a net sale of 4,587,600 shares. During the past 18 months, 9,994,200 shares of Cutia Therapeutics (HKSE:02487) were sold and 497,400 shares were bought by its insiders, resulting in a net sale of 9,496,800 shares.

Cutia Therapeutics (HKSE:02487)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cutia Therapeutics Insider Transactions

No Available Data

6 Dimensions Capital, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for 6 Dimensions Capital, L.P.. Currently GuruFocus does not have mailing address information for 6 Dimensions Capital, L.P..

Discussions on 6 Dimensions Capital, L.P.

No discussions yet.